Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Equity (2016 - 2025)

Historic Return on Equity for Theravance Biopharma (TBPH) over the last 12 years, with Q3 2025 value amounting to 0.1%.

  • Theravance Biopharma's Return on Equity rose 3600.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.33% for FY2024, which is 1600.0% down from last year.
  • As of Q3 2025, Theravance Biopharma's Return on Equity stood at 0.1%, which was up 3600.0% from 0.03% recorded in Q2 2025.
  • Over the past 5 years, Theravance Biopharma's Return on Equity peaked at 15.09% during Q3 2022, and registered a low of 0.39% during Q1 2025.
  • In the last 5 years, Theravance Biopharma's Return on Equity had a median value of 0.16% in 2023 and averaged 1.1%.
  • In the last 5 years, Theravance Biopharma's Return on Equity soared by 149800bps in 2022 and then crashed by -152600bps in 2023.
  • Quarter analysis of 5 years shows Theravance Biopharma's Return on Equity stood at 0.2% in 2021, then skyrocketed by 1155bps to 2.09% in 2022, then tumbled by -111bps to 0.24% in 2023, then tumbled by -47bps to 0.35% in 2024, then surged by 127bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.03% for Q2 2025, and 0.39% during Q1 2025.